(Reuters) – Novavax Inc said on Monday it had submitted an application to the U.S. Food and Drugs Administration for an emergency use authorization for its COVID-19 vaccine.
(Reporting by Leroy Leo)
Novavax files for U.S. authorization of COVID-19 vaccine
Jan 31, 2022 | 1:54 PM
